RECRUITINGINTERVENTIONAL
The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
To Determine the Efficacy of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
About This Trial
Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.
Who May Be Eligible (Plain English)
Who May Qualify:
1. Presenting to the urology clinic for catheter removal
2. Must be 18 years or older.
3. The patient must be able to understand and willing to provide willing to sign a consent form as described in this study protocol.
4. Must be willing to complete a post-catheter removal survey
Who Should NOT Join This Trial:
1. Allergy or adverse reaction to chlorohexidine gluconate
2. Under the age of 18
3. Refuse to provide willing to sign a consent form
4. On antibiotic therapy for any indication.
5. Women who are pregnant or breastfeeding
6. Signs of skin or systemic infection
7. Patients undergoing catheter exchange
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Presenting to the urology clinic for catheter removal
2. Must be 18 years or older.
3. The patient must be able to understand and willing to provide informed consent as described in this study protocol.
4. Must be willing to complete a post-catheter removal survey
Exclusion Criteria:
1. Allergy or adverse reaction to chlorohexidine gluconate
2. Under the age of 18
3. Refuse to provide informed consent
4. On antibiotic therapy for any indication.
5. Women who are pregnant or breastfeeding
6. Signs of skin or systemic infection
7. Patients undergoing catheter exchange
Treatments Being Tested
OTHER
0.05% Chlorhexidine Gluconate
0.05% CHG is instilled into the bladder prior to trial of void.
OTHER
Normal Saline
Bladder is back filled with normal saline.
Locations (1)
The Ohio State University
Columbus, Ohio, United States